Accenture, a technology services company, has gotten executives from CVS and Rite Aid to join a group of industry leaders who will assess the potential of radio frequency identification (RFID) technology. Accenture is serving as program manager for the group of pharmaceutical manufacturers, distributors, and retailers. Also, the Healthcare Distribution Management Association and the National Association of Chain Drug Stores are lending their support by providing their members with additional information and education-related opportunities for the program, according to Accenture.
The project will look at application of RFID in 3 areas:
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs